Q2 Earnings Beats Across Sectors: AbbVie EPS $3.65 vs $2.19 est, Chevron $6.11 vs $4.24 est, nVent $1.45 vs $0.93 est

A cluster of notable Q2 earnings beats highlights broad-based corporate outperformance this earnings season, with AbbVie, Chevron, and nVent Electric all delivering substantial earnings-per-share beats versus analyst estimates—alongside Greif's Q3 beat—though GuruFocus valuation flags on some names temper the unambiguously positive read.

• AbbVie Q2 EPS of $3.65 beat the $2.19 estimate by 67%, driven by Skyrizi and Rinvoq immunology franchise strength; GF Score 76/100
• Chevron Q2 EPS of $6.11 beat the $4.24 estimate by 44% on record US production, though GF Score 67 signals potential overvaluation at current energy prices
• nVent Electric Q2 EPS of $1.45 crushed the $0.93 estimate by 56%, with GF Score 93/100 placing it among the highest-quality industrial names on the composite metric

This multi-company earnings batch reveals a consistent theme of analyst conservatism: all four companies—AbbVie, Chevron, nVent, and Greif—beat consensus estimates by substantial margins, suggesting sell-side models had not fully incorporated the demand strength in each company's end markets. AbbVie's 67% EPS beat reflects the faster-than-modeled Skyrizi/Rinvoq commercial ramp; Chevron's 44% beat reflects higher-than-expected US Permian Basin production volumes and favorable crude price realizations.

nVent Electric's 56% EPS beat is arguably the most striking from a quality perspective, as its GF Score of 93/100 places it in the top tier of large-cap industrial quality composites. EPS of $1.45 versus a $0.93 estimate, combined with revised upward full-year guidance, signals that nVent's electrical enclosures and thermal management solutions are capturing significant data center and industrial electrification demand—a structural growth story that analyst models had underestimated. Greif's Q3 EPS of $1.37 beat the $1.11 estimate in industrial packaging, rounding out a broad sweep of beats.

The GuruFocus valuation flags on Chevron (GF Score 67) and the lower score on Greif (GF Score 71) introduce an important nuance: beating estimates does not automatically translate into undervaluation. Commodity-driven beats at Chevron and Greif can be temporary margin tailwinds that reverse as energy prices normalize. nVent's combination of high beat magnitude and high GF Score stands apart as a structurally strong name in this group, while AbbVie's complex picture (big beat + guidance cut from Apogee deal) requires a longer-horizon lens.

Source: GuruFocus | 4 sources